Author Question: A growing number of cigar manufacturers in the Caribbean and Central America have begun producing ... (Read 94 times)

captainjonesify

  • Hero Member
  • *****
  • Posts: 543
A growing number of cigar manufacturers in the Caribbean and Central America have begun producing and exporting cigars to the U.S. market. How has this affected the equilibrium price and quantity of cigars?
 
  What will be an ideal response?

Question 2

Why are some of the markets that provide information likely to be dominated by monopolies?
 
  What will be an ideal response?



ultraflyy23

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

The supply curve for cigars shifted to the right resulting in a lower equilibrium price and higher equilibrium quantity.

Answer to Question 2

Objective information about, say, the quality of a good or service or the risk associated with a particular activity is costly to obtain. Once it is obtained, however, the marginal cost of disseminating it is low. With the low marginal cost, the firm can enjoy significant economies of scale, so these markets might be close to natural monopolies, that is, a market in which one firm can meet the demand at lower cost than could two or more firms.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library